These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32797466)

  • 1. Rosmarinic Acid Intravitreal Implants: A New Therapeutic Approach for Ocular Neovascularization.
    Vieira LC; Moreira CPS; Castro BFM; Cotta OAL; Silva LM; Fulgêncio GO; Silva-Cunha A; Fialho SL
    Planta Med; 2020 Nov; 86(17):1286-1297. PubMed ID: 32797466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
    De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
    Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-Loaded Intravitreal Implant for Effective Treatment of Experimental Uveitis.
    Paiva MRB; Vasconcelos-Santos DV; Vieira LC; Fialho SL; Silva-Cunha A
    AAPS PharmSciTech; 2021 Jan; 22(1):35. PubMed ID: 33404988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide-Loaded Poly(Lactic-co-Glycolic Acid) Intravitreal Implants: In Vitro and In Vivo Evaluation.
    Solano AGR; de Fátima Pereira A; de Faria LGA; Fialho SL; de Oliveira Patricio PS; da Silva-Cunha A; Fulgêncio GO; da Silva GR; Pianetti GA
    AAPS PharmSciTech; 2018 May; 19(4):1652-1661. PubMed ID: 29516291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.
    Kim J; Lima E Silva R; Shmueli RB; Mirando AC; Tzeng SY; Pandey NB; Ben-Akiva E; Popel AS; Campochiaro PA; Green JJ
    Acta Biomater; 2019 Oct; 97():451-460. PubMed ID: 31374338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a method to quantify clindamycin in vitreous humor of rabbits' eyes by UPLC-MS/MS: application to a comparative pharmacokinetic study and in vivo ocular biocompatibility evaluation.
    Fernandes-Cunha GM; Gouvea DR; Fulgêncio Gde O; Rezende CM; da Silva GR; Bretas JM; Fialho SL; Lopes NP; Silva-Cunha A
    J Pharm Biomed Anal; 2015 Jan; 102():346-52. PubMed ID: 25459934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic activity of PLGA-Lupeol implants for potential intravitreal applications.
    Soares DCF; de Paula Oliveira DC; Barcelos LS; Barbosa AS; Vieira LC; Townsend DM; Rubello D; de Barros ALB; Duarte LP; Silva-Cunha A
    Biomed Pharmacother; 2017 Aug; 92():394-402. PubMed ID: 28558353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.
    Fernandes-Cunha GM; Fialho SL; da Silva GR; Silva-Cunha A; Zhao M; Behar-Cohen F
    Pharm Res; 2017 May; 34(5):1083-1092. PubMed ID: 28224388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
    Souza MC; Fialho SL; Souza PA; Fulgêncio GO; Da Silva GR; Silva-Cunha A
    Curr Eye Res; 2014 Jan; 39(1):99-102. PubMed ID: 24325382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression.
    Kim JH; Lee BJ; Kim JH; Yu YS; Kim MY; Kim KW
    Eur J Pharmacol; 2009 Aug; 615(1-3):150-4. PubMed ID: 19470386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pharmacokinetics and safety of a humanized monoclonal antibody in rabbits after intravitreal administration of a solution or a PLGA microsphere formulation.
    Mordenti J; Thomsen K; Licko V; Berleau L; Kahn JW; Cuthbertson RA; Duenas ET; Ryan AM; Schofield C; Berger TW; Meng YG; Cleland J
    Toxicol Sci; 1999 Nov; 52(1):101-6. PubMed ID: 10568703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel.
    Zhang L; Shen W; Luan J; Yang D; Wei G; Yu L; Lu W; Ding J
    Acta Biomater; 2015 Sep; 23():271-281. PubMed ID: 26004219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and
    Narvekar P; Bhatt P; Fnu G; Sutariya V
    Assay Drug Dev Technol; 2019; 17(4):167-177. PubMed ID: 31184962
    [No Abstract]   [Full Text] [Related]  

  • 16. Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1997 Jul; 16(7):633-9. PubMed ID: 9222079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo release and retinal safety of intravitreal implants of thalidomide in rabbit eyes and antiangiogenic effect on the chorioallantoic membrane.
    Fialho SL; Souza PA; Fulgêncio GO; Miranda MM; Pereira BG; Haddad A; Messias A; Jorge R; Silva-Cunha A
    J Drug Target; 2013 Nov; 21(9):837-45. PubMed ID: 23952807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleral plug of biodegradable polymers for controlled drug release in the vitreous.
    Hashizoe M; Ogura Y; Kimura H; Moritera T; Honda Y; Kyo M; Hyon SH; Ikada Y
    Arch Ophthalmol; 1994 Oct; 112(10):1380-4. PubMed ID: 7945044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases.
    Yang C; Jiang L; Bu S; Zhang L; Xie X; Zeng Q; Zhu D; Zheng Y
    J Biomed Nanotechnol; 2013 Sep; 9(9):1617-23. PubMed ID: 23980509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyes.
    Bhagat R; Zhang J; Farooq S; Li XY
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):854-8. PubMed ID: 25411827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.